Title |
Harnessing natural product assembly lines: structure, promiscuity, and engineering
|
---|---|
Published in |
Journal of Industrial Microbiology & Biotechnology, March 2016
|
DOI | 10.1007/s10295-015-1704-8 |
Pubmed ID | |
Authors |
Christopher C Ladner, Gavin J Williams |
Abstract |
Many therapeutically relevant natural products are biosynthesized by the action of giant mega-enzyme assembly lines. By leveraging the specificity, promiscuity, and modularity of assembly lines, a variety of strategies has been developed that enables the biosynthesis of modified natural products. This review briefly summarizes recent structural advances related to natural product assembly lines, discusses chemical approaches to probing assembly line structures in the absence of traditional biophysical data, and surveys efforts that harness the inherent or engineered promiscuity of assembly lines for the synthesis of non-natural polyketides and non-ribosomal peptide analogues. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 33% |
Australia | 1 | 17% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 3 | 50% |
Members of the public | 3 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 4% |
Japan | 1 | 1% |
Unknown | 86 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 30 | 33% |
Researcher | 12 | 13% |
Student > Master | 12 | 13% |
Student > Bachelor | 9 | 10% |
Student > Doctoral Student | 6 | 7% |
Other | 15 | 16% |
Unknown | 7 | 8% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 26 | 29% |
Biochemistry, Genetics and Molecular Biology | 25 | 27% |
Chemistry | 19 | 21% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Chemical Engineering | 3 | 3% |
Other | 5 | 5% |
Unknown | 10 | 11% |